Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical study of HST-001 in men with androgenic alopecia

Next Previous
X
Search
Trial Profile

A clinical study of HST-001 in men with androgenic alopecia

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 18 Feb 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs HST 001 (Primary)
  • Indications Alopecia
  • Focus Therapeutic Use
  • Sponsors Histogen [CEASED]

    • Most Recent Events

    • 18 Feb 2021 New trial record
    • 16 Feb 2021 According to a Histogen media release, the company has begun planning for this more substantive clinical trial in men with androgenic alopecia which is expected to commence in the second half of 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top